ReachRxResearch
Home
Research
Sign Up
Study limitation
Back to Research Hub
  1. Home
  2. Research Hub
  3. Study limitation

Macrophage lipid signaling drives glioblastoma invasion and represents a therapeutic vulnerability

Study limitation reported by the research below: “The relative benefit of LPAR vs. YAP/TAZ targeting is described as context-dependent, and the specific determinants of that context are not yet defined.”

Papers